CompletedNot Applicable

LifeVac Survey Study

United States2,930 participantsStarted 2024-06-24

Plain-language summary

This observational, non-interventional survey study is intended to explore user experiences with the LifeVac airway clearance device, with a particular emphasis on real-world application in choking emergencies in the USA. This study seeks to gather valuable insights from a representative sample of the LifeVac device purchaser base. The main questions the study aims to answer are: 1. Is the LifeVac device safe for individuals experiencing a choking emergency? 2. Is the LifeVac device successful in removing an obstruction during a choking incident? Participants: Purchasers of the LifeVac device.

Who can participate

Age range1 Year

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Purchases of the LifeVac device Original database: all purchasers of the LifeVac device from the LifeVac website starting in 2015 until April 2024, a timeframe that yields a database of above 450,000 individuals with no email duplications and third party suppliers. Survey batches: randomly selected sample of 50,000 purchasers (10% of the database). Number of batches required will be based on response rate. * English speaking * Ability to understand and accept the consent form Exclusion Criteria: * Did not purchase a LifeVac device * Third party suppliers * Non-English speakers (as LifeVac labeling and survey materials are only available in English) * Unwilling or unable to accept the consent form

What they're measuring

Primary Safety Endpoint

Timeframe: Up to 1 week

Primary Effectiveness Endpoint

Timeframe: Up to 1 week

Trial details

NCT IDNCT06659796

SponsorLifeVac, LLC

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-01-31

View on ClinicalTrials.gov More Airway Obstruction trials